DePuy Synthes Appoints Christina Zamarro as Chief Financial Officer
DePuy Synthes, a global leader in orthopaedic technologies and solutions, today announced the appointment of Christina Zamarro as Chief Financial Officer, DePuy Synthes, effective July 13, 2026.
DePuy Synthes Announces Agreement to Acquire Miniature Radiofrequency Tracking Technology Across its Joint Reconstruction Portfolio
DePuy Synthes, a global leader in orthopaedic technologies and solutions, today announced a definitive agreement to acquire selective rights to develop, manufacture and commercialize Gemtrack technology across its Joints portfolio, including shoulder, hip and knee, for both navigation and robotic applications. Gemtrack is a proprietary tracking technology developed by MinMaxMedical (MMM), a Grenoble-based pioneer in medtech and surgical innovation.
DePuy Synthes Enters Exclusive U.S., Canada and Australia Distribution Agreement for CGBIO’s NOVOSIS
DePuy Synthes, a global leader in orthopaedic technologies and solutions, today announced an exclusive distribution agreement1 with CGBIO, a biotechnology company specializing in regenerative medicine, for the development and commercialization of NOVOSIS, an advanced bone graft substitute containing growth factors, across its orthopaedic portfolio including spine, craniomaxillofacial (CMF), and trauma.
